Trial Outcomes & Findings for Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks (NCT NCT00329732)
NCT ID: NCT00329732
Last Updated: 2015-05-06
Results Overview
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
2 participants
Primary outcome timeframe
30 minutes
Results posted on
2015-05-06
Participant Flow
Participant milestones
| Measure |
Lidocaine/Bupivicaine
|
Saline (Placebo)
|
|---|---|---|
|
Overall Study
STARTED
|
2
|
0
|
|
Overall Study
COMPLETED
|
2
|
0
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks
Baseline characteristics by cohort
| Measure |
Lidocaine/Bupivicaine
n=2 Participants
|
Saline (Placebo)
|
Total
n=2 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 participants
n=5 Participants
|
—
|
0 participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
2 participants
n=5 Participants
|
—
|
2 participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 participants
n=5 Participants
|
—
|
0 participants
n=5 Participants
|
|
Gender
Female
|
2 participants
n=5 Participants
|
—
|
2 participants
n=5 Participants
|
|
Gender
Male
|
0 participants
n=5 Participants
|
—
|
0 participants
n=5 Participants
|
|
Region of Enrollment
United States
|
2 participants
n=5 Participants
|
—
|
2 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 30 minutesPopulation: No analysis was done. Study was terminated.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 30 minutesOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 30 minutesOutcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 30 minutesOutcome measures
Outcome data not reported
Adverse Events
Lidocaine/Bupivicaine
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Saline (Placebo)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place